James C. Cusack

7.1k total citations · 2 hit papers
89 papers, 5.1k citations indexed

About

James C. Cusack is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, James C. Cusack has authored 89 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 30 papers in Molecular Biology and 25 papers in Surgery. Recurrent topics in James C. Cusack's work include Colorectal Cancer Treatments and Studies (16 papers), Colorectal Cancer Surgical Treatments (15 papers) and Colorectal and Anal Carcinomas (14 papers). James C. Cusack is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Colorectal Cancer Surgical Treatments (15 papers) and Colorectal and Anal Carcinomas (14 papers). James C. Cusack collaborates with scholars based in United States, Uganda and United Kingdom. James C. Cusack's co-authors include Albert S. Baldwin, Rong Liu, Cun-Yu Wang, Julian Adams, Peter J. Elliott, Jack A. Roth, Laurie B. Owen‐Schaub, Michael E. Houston, Derek J. Erstad and Sybil M. Santee and has published in prestigious journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

James C. Cusack

84 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

1999 889 citations James C. Cusack et al. profile →
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression

1995 615 citations Laurie B. Owen‐Schaub, Wei Zhang et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James C. Cusack United States	35	2.7k	2.6k	1.3k	787	567	89	5.1k
Stephen A. Cannistra United States	30	1.9k 0.7×	2.0k 0.8×	756 0.6×	611 0.8×	718 1.3×	46	5.1k
Luigi Marchionni United States	41	1.6k 0.6×	2.7k 1.0×	1.4k 1.1×	539 0.7×	595 1.0×	136	5.1k
Jen Jen Yeh United States	39	3.2k 1.2×	3.2k 1.2×	1.7k 1.3×	1.3k 1.7×	651 1.1×	110	6.5k
Lanjing Zhang United States	28	2.8k 1.0×	2.2k 0.8×	1.2k 0.9×	686 0.9×	488 0.9×	126	5.0k
Madappa N. Kundranda United States	16	2.4k 0.9×	2.5k 1.0×	1.5k 1.2×	901 1.1×	403 0.7×	66	5.8k
Adam J. Bass United States	38	2.1k 0.8×	2.8k 1.1×	805 0.6×	1.3k 1.6×	474 0.8×	94	5.5k
Devalingam Mahalingam United States	41	2.0k 0.8×	2.9k 1.1×	922 0.7×	406 0.5×	655 1.2×	186	5.4k
Andra R. Frost United States	44	1.8k 0.7×	3.3k 1.2×	1.1k 0.9×	671 0.9×	400 0.7×	120	5.7k
Thomas Rutherford United States	46	2.4k 0.9×	2.9k 1.1×	1.4k 1.1×	838 1.1×	1.2k 2.2×	195	7.9k
M. Marty France	41	3.5k 1.3×	1.4k 0.5×	1.4k 1.1×	572 0.7×	601 1.1×	128	6.3k

Countries citing papers authored by James C. Cusack

Since Specialization

Citations

This map shows the geographic impact of James C. Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Cusack more than expected).

Fields of papers citing papers by James C. Cusack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Cusack. The network helps show where James C. Cusack may publish in the future.

Co-authorship network of co-authors of James C. Cusack

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Cusack. A scholar is included among the top collaborators of James C. Cusack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Cusack. James C. Cusack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Jinjin, et al.. (2025). Imaging in Hyperthermic Intraperitoneal Chemotherapy. Radiographics. 45(5). e240124–e240124.

Kim, Daniel W., Grace C. Lee, Aparna R. Parikh, et al.. (2025). Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation. The Cancer Journal. 31(1).

Dai, Rui, Bridget N. Kelly, David L. Berger, et al.. (2024). The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development. Cancers. 16(3). 676–676. 13 indexed citations

Cusack, James C., et al.. (2023). Diagnostic Sensitivity of Unenhanced CT for Cerebral Venous Thrombosis: Can Clot Density Measurement Replace CT Venogram?. SHILAP Revista de lepidopterología. 33(2). 187–194. 1 indexed citations

Peponis, Thomas, Caitlin Stafford, James C. Cusack, et al.. (2021). The growing trend for no primary surgery in colorectal cancer. Colorectal Disease. 23(10). 2659–2670. 1 indexed citations

Kamran, Sophia C., Christine E. Eyler, Jochen K. Lennerz, et al.. (2020). Evolutionary Analysis of Pre- and Post-treatment Molecular Diversity in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation (CRT) and a KRAS Mutation-targeted Radiosensitizer. International Journal of Radiation Oncology*Biology*Physics. 108(3). S57–S57.

Debas, Haile T., Olusegun Isaac Alatise, Charles M. Balch, et al.. (2019). Academic Partnerships in Global Surgery. Annals of Surgery. 271(3). 460–469. 22 indexed citations

Mitra, Devarati, Theodore S. Hong, Nora Horick, et al.. (2017). Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Advances in Radiation Oncology. 2(2). 110–117. 39 indexed citations

Chan, Carlos H.F., Tristan Penson, Yosef Landesman, et al.. (2015). XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer. Clinical Cancer Research. 22(7). 1663–1673. 36 indexed citations

10.

Sahani, Dushyant V., et al.. (2014). Current Status of Imaging and Emerging Techniques to Evaluate Liver Metastases From Colorectal Carcinoma. Annals of Surgery. 259(5). 861–872. 49 indexed citations

11.

Chung, Hye Won, Yosef Landesman, William Senapedis, et al.. (2013). CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma. Molecular Cancer Therapeutics. 12(7). 1171–1179. 57 indexed citations

12.

Russo, Andrea, David P. Ryan, Darrell R. Borger, et al.. (2013). Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer. Journal of Gastrointestinal Cancer. 45(1). 34–39. 34 indexed citations

13.

Nardi, Valentina, Youngchul Song, Juan A. Santamaria‐Barria, et al.. (2012). Activation of PI3K Signaling in Merkel Cell Carcinoma. Clinical Cancer Research. 18(5). 1227–1236. 87 indexed citations

14.

Drohan, Brian, Constance A. Roche, James C. Cusack, & Kevin S. Hughes. (2012). Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers. Annals of Surgical Oncology. 19(6). 1732–1737. 77 indexed citations

15.

Cusack, James C., et al.. (2005). Oral proteasome inhibitor (NPI-0052) enhances sensitivity to combination Gemcitabine and Erbitux in a pancreatic cancer xenograft model. Cancer Research. 65. 1167–1167. 1 indexed citations

16.

Weaver, Kyle D., Susan Yeyeodu, James C. Cusack, A S Baldwin, & Matthew G. Ewend. (2003). Potentiation of Chemotherapeutic Agents following Antagonism of Nuclear Factor kappa B in Human Gliomas. Journal of Neuro-Oncology. 61(3). 187–196. 83 indexed citations

17.

Cusack, James C. & Kenneth K. Tanabe. (2002). Introduction to cancer gene therapy. Surgical Oncology Clinics of North America. 11(3). 497–519. 17 indexed citations

18.

Cusack, James C., F R Spitz, Duc Nguyen, et al.. (1996). High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus.. PubMed. 3(4). 245–9. 27 indexed citations

19.

Owen‐Schaub, Laurie B., Wei Zhang, James C. Cusack, et al.. (1995). Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression. Molecular and Cellular Biology. 15(6). 3032–3040. 615 indexed citations breakdown →

20.

Goedegebuure, Peter S., et al.. (1994). Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy. Surgical Oncology. 3(2). 79–89. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact